Methods and systems for engineering conduction deviation features from biophysical signals for use in characterizing physiological systems
A clinical evaluation system and method are disclosed that facilitate the use of one or more conduction deviation features or parameters determined from biophysical signals such as cardiac or biopotentials signals. Conduction derivation features or parameters may include VD conduction derivation features or parameters and/or VD conduction derivation Poincaré features or parameters. The conduction derivation features or parameters can be used in a model or classifier (e.g., a machine-learned classifier) to estimate metrics associated with the physiological state of a patient, including for the presence or non-presence of a disease, a medical condition, or an indication of either. The estimated metric may be used to assist a physician or other healthcare provider in diagnosing the presence or non-presence and/or severity and/or localization of diseases or conditions or in the treatment of said diseases or conditions.
1 . A method for non-invasively assessing a cardiac disease state or abnormal condition of a subject, the method comprising:
obtaining, by one or more processors, a biophysical signal data set of the subject comprising a plurality of cardiac signals;
generating, by the one or more processors, a high-energy subspace model of the plurality of cardiac signals, wherein the high-energy subspace model is generated from a signal-modeling algorithm that generates an energy subspace that includes only a top percentile of energy of each signal through a selection of one or more candidate signals;
determining, by the one or more processors, a residue model from the high-energy subspace model;
determining, by the one or more processors and based, at least in part, on the residue model, values of one or more conduction deviation properties associated with ventricular depolarization within the plurality of cardiac signals; and
determining, by the one or more processors, an estimated value for a presence of a metric associated with the cardiac disease state or abnormal condition based, in part, on an application of the determined values of the one or more conduction deviation properties to an estimation model for the metric,
wherein the estimated value for of the presence of the metric is used in the estimation model to non-invasively estimate the presence or non-presence of the cardiac disease state or condition for use in a diagnosis of the cardiac disease state or condition or to direct treatment of the cardiac disease state or condition.
2 . The method of claim 1 , wherein the steps of determining the values of one or more conduction deviation properties associated with ventricular depolarization comprises:
determining, by the one or more processors, one or more values of one or more features extracted from the residue model associated with conduction skipping.
3 . The method of claim 2 , wherein the one or more features are selected from the group consisting of:
a feature associated with an assessed number of conduction skipping identified within a depolarization associated portion of the residue model;
a feature associated an assessed conduction distance identified with the depolarization associated portion of the residue model;
a feature associated with a time index of a maximum conduction skipping event in the depolarization associated portion of the residue model;
a feature associated with a tonicity of skipping peaks identified within the depolarization associated portion of the residue model; and
a feature associated with a statistical assessment of an assessed accumulative conduction distance determined within the depolarization associated portion of the residue model.
4 . The method of claim 1 , wherein the steps of determining the values of one or more conduction deviation properties associated with ventricular depolarization comprises:
determining, by the one or more processors, a three-dimensional residue model from the high-energy subspace model and the plurality of cardiac signals; and
determining, by the one or more processors, one or more values of features extracted from the three-dimensional residue model associated with conduction skipping.
5 . The method of claim 4 , wherein the one or more features are selected from the group consisting of:
a feature associated with a geometric parameter generated from a Poincaré model derived from the three-dimensional residue model; and
a feature associated with an alpha radius of an alpha shape generated from the three-dimensional residue model.
6 . The method of claim 5 , wherein the geometric parameter is selected from the group consisting of an alpha radius parameter, a perimeter parameter, a surface area parameter, a parameter associated with a ratio of the perimeter over a surface area, a density parameter, a void parameter, and a porosity parameter.
7 . The method of claim 5 , wherein the geometric parameter has an associated geometric shape comprising an Alpha Hull shape or a Convex Hull shape.
8 . The method of claim 1 , wherein the signal-modeling algorithm is based on a Fourier analysis.
9 . The method of claim 1 , wherein the signal-modeling algorithm is based on a Fourier analysis or on a sparse decomposition algorithm.
10 . The method of claim 1 further comprising:
causing, by the one or more processors, generation of a visualization of the estimated value for the presence of the cardiac disease state or abnormal condition, wherein the generated visualization is rendered and displayed at a display of a computing device and/or presented in a report.
11 . The method of claim 1 , wherein the values of the one or more conduction deviation properties associated with ventricular depolarization are used in the estimation model selected from the group consisting of a linear model, a decision tree model, a random forest model, a support vector machine model, and a neural network model.
12 . The method of claim 1 , wherein the estimation model further includes features selected from the group consisting of:
one or more depolarization or repolarization wave propagation associated features;
one or more depolarization wave propagation deviation associated features;
one or more cycle variability associated features;
one or more dynamical system associated features;
one or more cardiac waveform topologic and variations associated features;
one or more PPG waveform topologic and variations associated features;
one or more cardiac or PPG signal power spectral density associated features;
one or more cardiac or PPG signal visual associated features; and
one or more predictability features.
13 . The method of claim 1 , wherein the cardiac disease state or abnormal condition is selected from the group consisting of coronary artery disease, pulmonary hypertension, pulmonary arterial hypertension, pulmonary hypertension due to left heart disease, rare disorders that lead to pulmonary hypertension, left ventricular heart failure or left-sided heart failure, right ventricular heart failure or right-sided heart failure, systolic heart failure, diastolic heart failure, ischemic heart disease, and arrhythmia.
14 . The method of claim 1 , further comprising:
acquiring, by one or more acquisition circuits of a measurement system, voltage gradient signals over one or more channels, wherein the voltage gradient signals are acquired at a frequency greater than about 1 kHz; and
generating, by the one or more acquisition circuits, the obtained biophysical signal data set from the acquired voltage gradient signals.
15 . The method of claim 1 , further comprising:
acquiring, by one or more acquisition circuits of a measurement system, one or more photoplethysmographic signals; and
generating, by the one or more acquisition circuits, the obtained biophysical signal data set from the acquired photoplethysmographic signals.
16 . The method of claim 1 , wherein the one or more processors are located in a cloud platform.
17 . The method of claim 1 , wherein the one or more processors are located in a local computing device.
18 . A system comprising:
a processor; and
a memory having instructions stored thereon, wherein execution of the instructions by the processor causes the processor to:
obtain a biophysical signal data set of a subject comprising a plurality of cardiac signals;
generate a high-energy subspace model of the plurality of cardiac signals, wherein the high-energy subspace model is generated from a signal-modeling algorithm that generates an energy subspace that includes only a top percentile of energy of each signal through a selection of one or more candidate signals;
determine a residue model from the high-energy subspace model;
determine, and based, at least in part, on the residue model, values of one or more conduction deviation properties associated with ventricular depolarization within the plurality of cardiac signals; and
determine an estimated value for a presence of a metric associated with a cardiac disease state or abnormal condition based, in part, on an application of the determined values of the one or more conduction deviation properties to an estimation model for the metric,
wherein the estimated value for of the presence of the metric is used in the estimation model to non-invasively estimate the presence or non-presence of the cardiac disease state or condition for use in a diagnosis of the cardiac disease state or condition or to direct treatment of the cardiac disease state or condition.
19 . A non-transitory computer readable medium having instructions stored thereon, wherein execution of the instructions by a processor causes the processor to:
obtain a biophysical signal data set of a subject comprising a plurality of cardiac signals;
generate a high-energy subspace model of the plurality of cardiac signals, wherein the high-energy subspace model is generated from a signal-modeling algorithm that generates an energy subspace that includes only a top percentile of energy of each signal through a selection of one or more candidate signals;
determine a residue model from the high-energy subspace model;
determine, and based, at least in part, on the residue model, values of one or more conduction deviation properties associated with ventricular depolarization within the plurality of cardiac signals; and
determine an estimated value for a presence of a metric associated with a cardiac disease state or abnormal condition based, in part, on an application of the determined values of the one or more conduction deviation properties to an estimation model for the metric,
wherein the estimated value for of the presence of the metric is used in the estimation model to non-invasively estimate the presence or non-presence of the cardiac disease state or condition for use in a diagnosis of the cardiac disease state or condition or to direct treatment of the cardiac disease state or condition.